Training program for postdoctoral fellows in tumor immunotherapy and immunology
UNC Immunotherapy Training Grant (IM-TAG)
This program at the University of North Carolina is helping new scientists learn about exciting ways to use the immune system to fight cancer, like developing vaccines and new therapies, so they can become experts and help improve treatments for patients.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10930107 on NIH RePORTER |
What this research studies
This program at the University of North Carolina at Chapel Hill trains postdoctoral fellows in the fields of tumor immunotherapy, tumor immunology, and stem cell transplantation immunology. The training involves mentorship from leading experts and focuses on innovative approaches such as vaccine design, adoptive cellular therapy, and understanding immune responses in the tumor microenvironment. Participants will engage in both basic and translational research, contributing to advancements in immune-based therapies. The program aims to address the shortage of trained investigators in these critical areas of cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for participation would be postdoctoral fellows interested in advancing their careers in tumor immunology and immunotherapy.
Not a fit: Patients who are not postdoctoral fellows or those not involved in academic research may not receive direct benefits from this program.
Why it matters
Potential benefit: If successful, this research could lead to improved immunotherapy strategies that enhance patient outcomes in cancer treatment.
How similar studies have performed: Previous training programs in immunotherapy have shown success in developing skilled researchers who contribute to significant advancements in cancer treatment.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Serody, Jonathan S. — Univ of North Carolina Chapel Hill
- Study coordinator: Serody, Jonathan S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.